![](/images/general/no_picture/200_user.png)
Geraldina Visconti
Examiner (ID: 121, Phone: (571)272-1334 , Office: P/1722 )
Most Active Art Unit | 1722 |
Art Unit(s) | 1506, 1795, 1752, 1113, 1722 |
Total Applications | 2553 |
Issued Applications | 2180 |
Pending Applications | 89 |
Abandoned Applications | 284 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 7422995
[patent_doc_number] => 20040229359
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-18
[patent_title] => 'Cloning vectors and vector components'
[patent_app_type] => new
[patent_app_number] => 10/740714
[patent_app_country] => US
[patent_app_date] => 2003-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 44267
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20040229359.pdf
[firstpage_image] =>[orig_patent_app_number] => 10740714
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/740714 | Cloning vectors and vector components | Dec 18, 2003 | Abandoned |
Array
(
[id] => 864209
[patent_doc_number] => 07368259
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-05-06
[patent_title] => 'Method for generating diversity'
[patent_app_type] => utility
[patent_app_number] => 10/733532
[patent_app_country] => US
[patent_app_date] => 2003-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 26
[patent_no_of_words] => 21801
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/368/07368259.pdf
[firstpage_image] =>[orig_patent_app_number] => 10733532
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/733532 | Method for generating diversity | Dec 10, 2003 | Issued |
Array
(
[id] => 7435845
[patent_doc_number] => 20040185030
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-23
[patent_title] => 'Methods and materials for treating inflammatory diseases'
[patent_app_type] => new
[patent_app_number] => 10/732386
[patent_app_country] => US
[patent_app_date] => 2003-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10978
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0185/20040185030.pdf
[firstpage_image] =>[orig_patent_app_number] => 10732386
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/732386 | Methods and materials for treating inflammatory diseases | Dec 9, 2003 | Abandoned |
Array
(
[id] => 7692717
[patent_doc_number] => 20070016969
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-18
[patent_title] => 'Expression vector for hirudin and transformed cells and transgenic animals containing said vector'
[patent_app_type] => utility
[patent_app_number] => 10/727145
[patent_app_country] => US
[patent_app_date] => 2003-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7737
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0016/20070016969.pdf
[firstpage_image] =>[orig_patent_app_number] => 10727145
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/727145 | Expression vector for hirudin and transformed cells and transgenic animals containing said vector | Dec 2, 2003 | Abandoned |
Array
(
[id] => 7295903
[patent_doc_number] => 20040214197
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-28
[patent_title] => 'Method of preparing polynucleotide fragments for use in shuffling, and shuffling of same'
[patent_app_type] => new
[patent_app_number] => 10/713006
[patent_app_country] => US
[patent_app_date] => 2003-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5051
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20040214197.pdf
[firstpage_image] =>[orig_patent_app_number] => 10713006
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/713006 | Method of preparing polynucleotide fragments for use in shuffling, and shuffling of same | Nov 16, 2003 | Issued |
Array
(
[id] => 7470484
[patent_doc_number] => 20040121381
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-24
[patent_title] => 'Methods and compositions for screening ICRAC modulators'
[patent_app_type] => new
[patent_app_number] => 10/691553
[patent_app_country] => US
[patent_app_date] => 2003-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9445
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0121/20040121381.pdf
[firstpage_image] =>[orig_patent_app_number] => 10691553
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/691553 | Methods and compositions for screening ICRAC modulators | Oct 23, 2003 | Abandoned |
Array
(
[id] => 7303199
[patent_doc_number] => 20040115176
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-17
[patent_title] => 'Fibrin-based tissue-engineered vasculature'
[patent_app_type] => new
[patent_app_number] => 10/692381
[patent_app_country] => US
[patent_app_date] => 2003-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 50
[patent_no_of_words] => 19063
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20040115176.pdf
[firstpage_image] =>[orig_patent_app_number] => 10692381
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/692381 | Fibrin-based tissue-engineered vasculature | Oct 22, 2003 | Abandoned |
Array
(
[id] => 7255750
[patent_doc_number] => 20040259764
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-23
[patent_title] => 'Reticulocyte depletion signatures'
[patent_app_type] => new
[patent_app_number] => 10/692330
[patent_app_country] => US
[patent_app_date] => 2003-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 13180
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0259/20040259764.pdf
[firstpage_image] =>[orig_patent_app_number] => 10692330
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/692330 | Reticulocyte depletion signatures | Oct 21, 2003 | Abandoned |
Array
(
[id] => 7474891
[patent_doc_number] => 20040168210
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-26
[patent_title] => 'Transgenic fish and beta-catenin signaling pathway model'
[patent_app_type] => new
[patent_app_number] => 10/679191
[patent_app_country] => US
[patent_app_date] => 2003-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 13633
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0168/20040168210.pdf
[firstpage_image] =>[orig_patent_app_number] => 10679191
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/679191 | Transgenic fish and β-catenin signaling pathway model | Oct 2, 2003 | Issued |
Array
(
[id] => 7251778
[patent_doc_number] => 20050074744
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-07
[patent_title] => 'Assays for evaluating anti-osteoarthritic activity'
[patent_app_type] => utility
[patent_app_number] => 10/675971
[patent_app_country] => US
[patent_app_date] => 2003-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6200
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20050074744.pdf
[firstpage_image] =>[orig_patent_app_number] => 10675971
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/675971 | Assays for evaluating anti-osteoarthritic activity | Oct 1, 2003 | Abandoned |
Array
(
[id] => 7116225
[patent_doc_number] => 20050069526
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2005-03-31
[patent_title] => 'Promoting Recovery from Damage to the Central Nervous System'
[patent_app_type] => utility
[patent_app_number] => 10/605456
[patent_app_country] => US
[patent_app_date] => 2003-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 17432
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A9/0069/20050069526.pdf
[firstpage_image] =>[orig_patent_app_number] => 10605456
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/605456 | Promoting Recovery from Damage to the Central Nervous System | Sep 29, 2003 | Abandoned |
Array
(
[id] => 7116225
[patent_doc_number] => 20050069526
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2005-03-31
[patent_title] => 'Promoting Recovery from Damage to the Central Nervous System'
[patent_app_type] => utility
[patent_app_number] => 10/605456
[patent_app_country] => US
[patent_app_date] => 2003-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 17432
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A9/0069/20050069526.pdf
[firstpage_image] =>[orig_patent_app_number] => 10605456
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/605456 | Promoting Recovery from Damage to the Central Nervous System | Sep 29, 2003 | Abandoned |
Array
(
[id] => 7304294
[patent_doc_number] => 20040115708
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-17
[patent_title] => 'Method of screening agents for the treatment and prevention of cancer and cachexia and the new use of specific agents for the treatment and prevention of cancer and cachexia'
[patent_app_type] => new
[patent_app_number] => 10/665221
[patent_app_country] => US
[patent_app_date] => 2003-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6510
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20040115708.pdf
[firstpage_image] =>[orig_patent_app_number] => 10665221
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/665221 | Method of screening agents for the treatment and prevention of cancer and cachexia and the new use of specific agents for the treatment and prevention of cancer and cachexia | Sep 16, 2003 | Abandoned |
Array
(
[id] => 7133457
[patent_doc_number] => 20040043004
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-04
[patent_title] => 'Caveolin-1 gene and polypeptide encoded thereby and methods of use thereof'
[patent_app_type] => new
[patent_app_number] => 10/398319
[patent_app_country] => US
[patent_app_date] => 2003-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 20009
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0043/20040043004.pdf
[firstpage_image] =>[orig_patent_app_number] => 10398319
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/398319 | Caveolin-1 gene and polypeptide encoded thereby and methods of use thereof | Sep 2, 2003 | Abandoned |
Array
(
[id] => 7224526
[patent_doc_number] => 20040072752
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-15
[patent_title] => 'Modulating cytokine or hormone signalling in an animal comprising up-regulating the expression of socs sequence in the animal'
[patent_app_type] => new
[patent_app_number] => 10/398863
[patent_app_country] => US
[patent_app_date] => 2003-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8108
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20040072752.pdf
[firstpage_image] =>[orig_patent_app_number] => 10398863
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/398863 | Modulating cytokine or hormone signalling in an animal comprising up-regulating the expression of socs sequence in the animal | Aug 28, 2003 | Abandoned |
Array
(
[id] => 7237747
[patent_doc_number] => 20050080029
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-14
[patent_title] => 'Methods for delivering compounds into a cell'
[patent_app_type] => utility
[patent_app_number] => 10/644080
[patent_app_country] => US
[patent_app_date] => 2003-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 23497
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0080/20050080029.pdf
[firstpage_image] =>[orig_patent_app_number] => 10644080
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/644080 | Methods for delivering compounds into a cell | Aug 19, 2003 | Abandoned |
Array
(
[id] => 7169109
[patent_doc_number] => 20040077576
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-22
[patent_title] => 'Minimal plasmid vectors that provide for persistent and high level gene expression and methods for using the same'
[patent_app_type] => new
[patent_app_number] => 10/642362
[patent_app_country] => US
[patent_app_date] => 2003-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7937
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20040077576.pdf
[firstpage_image] =>[orig_patent_app_number] => 10642362
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/642362 | Minimal plasmid vectors that provide for persistent and high level gene expression and methods for using the same | Aug 13, 2003 | Abandoned |
Array
(
[id] => 806903
[patent_doc_number] => 07420100
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-09-02
[patent_title] => 'Methods and compositions relating to HDAC 4 and 5 regulation of cardiac gene expression'
[patent_app_type] => utility
[patent_app_number] => 10/637403
[patent_app_country] => US
[patent_app_date] => 2003-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 26
[patent_no_of_words] => 29113
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/420/07420100.pdf
[firstpage_image] =>[orig_patent_app_number] => 10637403
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/637403 | Methods and compositions relating to HDAC 4 and 5 regulation of cardiac gene expression | Aug 7, 2003 | Issued |
Array
(
[id] => 7389534
[patent_doc_number] => 20040083001
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-29
[patent_title] => 'Intervertebral disc'
[patent_app_type] => new
[patent_app_number] => 10/312655
[patent_app_country] => US
[patent_app_date] => 2003-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10377
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0083/20040083001.pdf
[firstpage_image] =>[orig_patent_app_number] => 10312655
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/312655 | Intervertebral disc | Aug 3, 2003 | Abandoned |
Array
(
[id] => 7046125
[patent_doc_number] => 20050250720
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-10
[patent_title] => 'Novel compound'
[patent_app_type] => utility
[patent_app_number] => 10/627633
[patent_app_country] => US
[patent_app_date] => 2003-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4998
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0250/20050250720.pdf
[firstpage_image] =>[orig_patent_app_number] => 10627633
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/627633 | Novel compound | Jul 27, 2003 | Abandoned |